Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback